ATTR Expanded Access Program (EAP) by Ionis

NCT03400098 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Amyloidosis, Hereditary

Interventions

DRUG: Inotersen

Sponsor

Ionis Pharmaceuticals, Inc.